Author: Shatizadeh, Somayeh; Yavarian, Jila; Rezaie, Farhad; Mahmoodi, Mahmood; Naseri, Maryam; Mokhtari Azad, Talat
Title: Epidemiological and clinical evaluation of children with respiratory virus infections Document date: 2014_9_22
ID: yibdumij_20
Snippet: In summary, respiratory virus infections (RVI) are a common cause of morbidity and mortality worldwide. Viral co infections and recently discovered viruses are involved in a significant percentage of acute RVI. Studies are being conducted to determine whether dual respiratory virus infections carry an increased risk for adverse outcomes or increased hospital stays for pediatric patients. Better understanding of the epidemiology of RVI may be used.....
Document: In summary, respiratory virus infections (RVI) are a common cause of morbidity and mortality worldwide. Viral co infections and recently discovered viruses are involved in a significant percentage of acute RVI. Studies are being conducted to determine whether dual respiratory virus infections carry an increased risk for adverse outcomes or increased hospital stays for pediatric patients. Better understanding of the epidemiology of RVI may be used for timely specific antiviral therapy, prophylactic and vaccination. This study described the demographic and clinical presentations of specific RVI in 202 children under the 6 years of age in Iran. Monitoring is necessary in a broader population and for a longer period of time in order to better delineate the clinical and epidemiological behavior of respiratory viruses in children. Although routine surveillance of respiratory viruses might not seem to be MJIRI, Vol. 28
Search related documents:
Co phrase search for related documents- adverse outcome and clinical demographic presentation: 1
- adverse outcome and co infection: 1, 2, 3, 4
- adverse outcome and common cause: 1, 2, 3, 4
- adverse outcome and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adverse outcome and increase risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adverse outcome and mortality morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adverse outcome and pediatric patient: 1
- antiviral therapy and co infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- antiviral therapy and common cause: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- antiviral therapy and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral therapy and increase risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antiviral therapy and mortality morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral therapy and pediatric patient: 1, 2
- broad population and increase risk: 1, 2, 3, 4
- broad population and mortality morbidity: 1, 2, 3, 4, 5, 6, 7, 8
- clinical demographic presentation and hospital stay: 1, 2, 3, 4, 5
- clinical demographic presentation and mortality morbidity: 1, 2
- co infection and common cause: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- co infection and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date